Direkt zum Inhalt
Merck
  • Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis.

Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis.

Nano convergence (2020-05-20)
Kateryna Levada, Stanislav Pshenichnikov, Alexander Omelyanchik, Valeria Rodionova, Aleksey Nikitin, Alexander Savchenko, Igor Schetinin, Dmitry Zhukov, Maxim Abakumov, Alexander Majouga, Mariia Lunova, Milan Jirsa, Barbora Smolková, Mariia Uzhytchak, Alexandr Dejneka, Oleg Lunov
ZUSAMMENFASSUNG

Iron oxide nanoparticles (IONs) are frequently used in various biomedical applications, in particular as magnetic resonance imaging contrast agents in liver imaging. Indeed, number of IONs have been withdrawn due to their poor clinical performance. Yet comprehensive understanding of their interactions with hepatocytes remains relatively limited. Here we investigated how iron oxide nanocubes (IO-cubes) and clusters of nanocubes (IO-clusters) affect distinct human hepatic cell lines. The viability of HepG2, Huh7 and Alexander cells was concentration-dependently decreased after exposure to either IO-cubes or IO-clusters. We found similar cytotoxicity levels in three cell lines triggered by both nanoparticle formulations. Our data indicate that different expression levels of Bcl-2 predispose cell death signaling mediated by nanoparticles. Both nanoparticles induced rather apoptosis than autophagy in HepG2. Contrary, IO-cubes and IO-clusters trigger distinct cell death signaling events in Alexander and Huh7 cells. Our data clarifies the mechanism by which cubic nanoparticles induce autophagic flux and the mechanism of subsequent toxicity. These findings imply that the cytotoxicity of ION-based contrast agents should be carefully considered, particularly in patients with liver diseases.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ammoniumacetat, ≥99.99% trace metals basis
Sigma-Aldrich
N-Hydroxysuccinimid, 98%
Sigma-Aldrich
1,2-Hexadecandiol, technical grade, 90%
Sigma-Aldrich
indanyl-1-carboxylic acid, AldrichCPR